C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Price:
32.87
CNY
-3.32%
Market Closed
Market Cap:
¥46.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
CN |
|
Hunan Friendship&Apollo Commercial Co Ltd
SZSE:002277
|
CN |
|
L
|
Luxchem Corporation Bhd
KLSE:LUXCHEM
|
MY |
|
I
|
Intellivate Capital Ventures Ltd
BSE:506134
|
IN |
|
HDFC Life Insurance Company Ltd
NSE:HDFCLIFE
|
IN |
|
N
|
Ningxia Younglight Chemicals Co Ltd
SZSE:000635
|
CN |
|
T
|
TANSH Global Food Group Co Ltd
HKEX:3666
|
CN |
Balance Sheet
Balance Sheet Decomposition
CSPC Innovation Pharmaceutical Co Ltd
CSPC Innovation Pharmaceutical Co Ltd
Balance Sheet Decomposition is not available for
CSPC Innovation Pharmaceutical Co Ltd
CSPC Innovation Pharmaceutical Co Ltd
Balance Sheet
CSPC Innovation Pharmaceutical Co Ltd
CSPC Innovation Pharmaceutical Co Ltd
Currency: CNY
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
151
|
68
|
156
|
473
|
1 138
|
1 232
|
2 192
|
3 422
|
859
|
769
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
1 232
|
2 192
|
3 422
|
859
|
769
|
|
| Cash Equivalents |
151
|
68
|
156
|
473
|
1 138
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
960
|
322
|
414
|
0
|
0
|
826
|
594
|
|
| Total Receivables |
172
|
272
|
349
|
365
|
329
|
434
|
732
|
581
|
661
|
881
|
|
| Accounts Receivables |
108
|
125
|
189
|
173
|
146
|
270
|
481
|
404
|
314
|
441
|
|
| Other Receivables |
64
|
146
|
160
|
192
|
182
|
164
|
250
|
176
|
347
|
440
|
|
| Inventory |
67
|
114
|
129
|
124
|
111
|
217
|
238
|
225
|
399
|
498
|
|
| Other Current Assets |
4
|
13
|
27
|
15
|
14
|
22
|
29
|
42
|
58
|
111
|
|
| Total Current Assets |
393
|
466
|
661
|
1 937
|
1 913
|
2 318
|
3 191
|
4 618
|
2 802
|
2 853
|
|
| PP&E Net |
509
|
594
|
655
|
685
|
737
|
610
|
1 071
|
2 339
|
2 708
|
2 905
|
|
| PP&E Gross |
509
|
594
|
655
|
685
|
737
|
610
|
1 071
|
2 339
|
2 708
|
2 905
|
|
| Accumulated Depreciation |
167
|
193
|
233
|
259
|
301
|
329
|
551
|
715
|
915
|
1 102
|
|
| Intangible Assets |
65
|
62
|
60
|
58
|
55
|
42
|
50
|
232
|
225
|
219
|
|
| Goodwill |
0
|
0
|
4
|
4
|
4
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
156
|
236
|
243
|
253
|
267
|
264
|
278
|
|
| Other Long-Term Assets |
2
|
7
|
12
|
13
|
10
|
12
|
19
|
17
|
22
|
22
|
|
| Other Assets |
0
|
0
|
4
|
4
|
4
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
969
N/A
|
1 129
+17%
|
1 391
+23%
|
2 852
+105%
|
2 955
+4%
|
3 226
+9%
|
4 584
+42%
|
7 472
+63%
|
6 022
-19%
|
6 276
+4%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
72
|
58
|
64
|
80
|
59
|
69
|
159
|
1 264
|
396
|
722
|
|
| Accrued Liabilities |
7
|
7
|
18
|
16
|
21
|
24
|
70
|
68
|
66
|
42
|
|
| Short-Term Debt |
0
|
46
|
33
|
13
|
5
|
0
|
30
|
10
|
10
|
33
|
|
| Current Portion of Long-Term Debt |
120
|
0
|
50
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
|
| Other Current Liabilities |
161
|
164
|
185
|
293
|
150
|
137
|
325
|
561
|
961
|
1 912
|
|
| Total Current Liabilities |
360
|
275
|
349
|
401
|
234
|
231
|
583
|
1 904
|
1 434
|
2 709
|
|
| Long-Term Debt |
0
|
50
|
0
|
0
|
0
|
0
|
20
|
1
|
0
|
530
|
|
| Deferred Income Tax |
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
1
|
2
|
|
| Minority Interest |
0
|
0
|
9
|
9
|
9
|
8
|
9
|
202
|
765
|
128
|
|
| Other Liabilities |
37
|
38
|
42
|
36
|
33
|
34
|
37
|
84
|
90
|
240
|
|
| Total Liabilities |
397
N/A
|
362
-9%
|
400
+10%
|
446
+12%
|
277
-38%
|
274
-1%
|
648
+137%
|
2 191
+238%
|
2 292
+5%
|
3 609
+57%
|
|
| Equity | |||||||||||
| Common Stock |
150
|
150
|
150
|
200
|
420
|
546
|
619
|
1 171
|
1 405
|
1 405
|
|
| Retained Earnings |
412
|
607
|
831
|
1 104
|
1 376
|
1 651
|
2 177
|
1 988
|
1 667
|
1 398
|
|
| Additional Paid In Capital |
10
|
10
|
10
|
1 102
|
882
|
756
|
1 138
|
2 125
|
977
|
181
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
321
|
321
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
4
|
|
| Total Equity |
572
N/A
|
767
+34%
|
991
+29%
|
2 406
+143%
|
2 678
+11%
|
2 952
+10%
|
3 936
+33%
|
5 281
+34%
|
3 731
-29%
|
2 667
-28%
|
|
| Total Liabilities & Equity |
969
N/A
|
1 129
+17%
|
1 391
+23%
|
2 852
+105%
|
2 955
+4%
|
3 226
+9%
|
4 584
+42%
|
7 472
+63%
|
6 022
-19%
|
6 276
+4%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
410
|
410
|
410
|
546
|
546
|
1 179
|
1 337
|
1 405
|
1 405
|
1 405
|
|
Switch to:
Switch to:
See Also
Discover More
